The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and testsThis article covers the last four months of deal data provided by Chris Dokomajilar of DealFormaOur team at PharmaShots…
